» Articles » PMID: 17003445

Dual Roles of Diadenosine Polyphosphates in Corneal Epithelial Cell Migration

Overview
Specialty Ophthalmology
Date 2006 Sep 28
PMID 17003445
Citations 12
Authors
Affiliations
Soon will be listed here.
Abstract

Purpose: To investigate the influence of diadenosine polyphosphates on the rate of corneal epithelial cell migration.

Methods: Primary corneal epithelial cell cultures were obtained from New Zealand White rabbits. Immunocytochemical experiments were performed by fixing the cells with 4% paraformaldehyde (PFA) and incubated with cytokeratin 3 primary antibody, which was subsequently incubated with a secondary IgG mouse labeled with FITC, and the cells were observed under confocal microscopy. Migration studies were performed by taking confluent monolayers that were wounded with a pipette tip and challenged with different di- and mononucleotides with or without P2 antagonist (n = 8 each treatment). For concentration-response analysis, compounds were tested in doses ranging from 10(-8) to 10(-3) M (n = 8). The stability of the dinucleotides was assayed by HPLC, with an isocratic method (n = 4).

Results: Cells under study were verified as corneal epithelial cells via the immunocytochemical analysis. Cell migration experiments showed that Ap4A, UTP, and ATP accelerated the rate of healing (5, 2.75, and 3 hours, respectively; P < 0.05; P < 0.001), whereas Ap3A, Ap5A, and UDP delayed it (6.5, 10, and 2 hours, respectively; P < 0.05). ADP did not modify the rate of migration. Antagonists demonstrated that Ap4A and Ap3A did activate different P2Y receptors mediating corneal wound-healing acceleration and delay. Concerning the possible degradation of the dinucleotides, it was almost impossible to detect any products resulting from their cleavage.

Conclusions: Based on the pharmacological profile of all the compounds tested, the two main P2Y receptors that exist in these corneal cells are a P2Y(2) receptor accelerating the rate of healing and a P2Y6 receptor that delays this process.

Citing Articles

Efficacy of Artificial Tears Based on an Extract of Containing Dinucleotides in a Rabbit Dry Eye Model.

Carpena-Torres C, Pintor J, Huete-Toral F, Martin-Gil A, Rodriguez-Pomar C, Martinez-Aguila A Int J Mol Sci. 2021; 22(21).

PMID: 34769429 PMC: 8584318. DOI: 10.3390/ijms222111999.


Ocular Purine Receptors as Drug Targets in the Eye.

Jacobson K, Civan M J Ocul Pharmacol Ther. 2016; 32(8):534-547.

PMID: 27574786 PMC: 5069731. DOI: 10.1089/jop.2016.0090.


A comparison of epithelial-to-mesenchymal transition and re-epithelialization.

Leopold P, Vincent J, Wang H Semin Cancer Biol. 2012; 22(5-6):471-83.

PMID: 22863788 PMC: 3595494. DOI: 10.1016/j.semcancer.2012.07.003.


Nucleotide receptors as targets in the pharmacological enhancement of dermal wound healing.

Gendaszewska-Darmach E, Kucharska M Purinergic Signal. 2011; 7(2):193-206.

PMID: 21519856 PMC: 3146642. DOI: 10.1007/s11302-011-9233-z.


The P2Y2 receptor mediates the epithelial injury response and cell migration.

Boucher I, Rich C, Lee A, Marcincin M, Trinkaus-Randall V Am J Physiol Cell Physiol. 2010; 299(2):C411-21.

PMID: 20427708 PMC: 2928627. DOI: 10.1152/ajpcell.00100.2009.